Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PPARgamma variants and complex diseases].

Sen-Lin Ji1, Qing-Yang Huang

  • 1College of life sciences, Central China Normal University, Wuhan, 430079, China. jisenlin2003@yahoo.com

Yi Chuan = Hereditas
|July 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Throughput Screening Reveals That CeeNU Acts as a New NLRP3 Inflammasome Inhibitor.

MedComm·2026
Same author

Electroacupuncture alleviates depression and gastrointestinal dysfunction by rebalancing GABAergic activity in the central amygdala.

World journal of psychiatry·2026
Same author

Exploring the Animal Models of Gastrointestinal and Emotional Comorbidity.

Brain and behavior·2025
Same author

Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687].

International immunopharmacology·2025
Same author

Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases.

International immunopharmacology·2025
Same author

New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3.

Journal of pharmaceutical analysis·2025
Same journal

Construction and implementation of an ICF-based integrated teaching model for genetic disease severity assessment.

Yi chuan = Hereditas·2026
Same journal

Identification and prenatal genetic testing of pathogenic variants in a case of myoclonus-dystonia syndrome.

Yi chuan = Hereditas·2026
Same journal

A novel strategy to enhance precise targeting of the RNA base editor mxABE.

Yi chuan = Hereditas·2026
Same journal

Functional study of the soybean rapid alkalinization factor <i>GmRALF34s</i> in response to saline-alkali stress.

Yi chuan = Hereditas·2026
Same journal

Role of <i>broad</i> in intestinal stem cells of adult <i>Drosophila</i>.

Yi chuan = Hereditas·2026
Same journal

The p53 R267W mutation intervenes p21-mediated cell cycle arrest and promotes proliferation and migration of lung cancer cells.

Yi chuan = Hereditas·2026
See all related articles

Peroxisome proliferator-activated receptor gamma (PPARγ) influences fat cell development and impacts metabolic diseases. Understanding PPARγ gene variations is crucial for preventing and treating type 2 diabetes, obesity, and cardiovascular conditions.

Area of Science:

  • Endocrinology and Molecular Biology

Context:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear hormone receptor primarily found in adipose tissue.
  • PPARγ regulates adipocyte differentiation and the expression of adipocytokines, playing a key role in metabolic regulation.
  • It serves as the molecular target for thiazolidinedione medications.

Purpose:

  • To explore the role of Peroxisome proliferator-activated receptor gamma (PPARγ) in metabolic processes.
  • To investigate the implications of PPARγ gene polymorphisms on pancreatic beta-cell function, insulin secretion, and insulin sensitivity.
  • To understand the association between PPARγ and the risk of complex diseases.

Summary:

  • PPARγ is central to adipocyte differentiation and adipokine gene expression in adipose tissue.
  • Gene polymorphisms in PPARγ can affect pancreatic beta-cell function, leading to altered insulin secretion and peripheral insulin sensitivity.

Related Experiment Videos

  • These genetic variations are linked to increased risks of type 2 diabetes, obesity, cardiovascular diseases, and cancer.

    • Impact:

    • Elucidating PPARγ's mechanism is vital for advancing the diagnosis, prevention, and treatment strategies for complex metabolic and non-metabolic diseases.
    • Findings could inform therapeutic targets for conditions associated with metabolic dysfunction and inflammation.
    • Understanding PPARγ's role enhances knowledge of nuclear receptor function in health and disease.